Covera-HS - 0025-2021-31 - (verapamil hydrochloride)

Alphabetical Index


Drug Information of Covera-HS

Product NDC: 0025-2021
Proprietary Name: Covera-HS
Non Proprietary Name: verapamil hydrochloride
Active Ingredient(s): 240    mg/1 & nbsp;   verapamil hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Covera-HS

Product NDC: 0025-2021
Labeler Name: G.D. Searle LLC Division of Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020552
Marketing Category: NDA
Start Marketing Date: 19960226

Package Information of Covera-HS

Package NDC: 0025-2021-31
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0025-2021-31)

NDC Information of Covera-HS

NDC Code 0025-2021-31
Proprietary Name Covera-HS
Package Description 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0025-2021-31)
Product NDC 0025-2021
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name verapamil hydrochloride
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 19960226
Marketing Category Name NDA
Labeler Name G.D. Searle LLC Division of Pfizer Inc
Substance Name VERAPAMIL HYDROCHLORIDE
Strength Number 240
Strength Unit mg/1
Pharmaceutical Classes Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]

Complete Information of Covera-HS


General Information